LAURA SIMEONE: Open Payments
NPI 1124324587 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,256 in 154 payments from 43 companies in 2025. Trend: 2023 $2,422 · 2024 $2,736 · 2025 $3,256
Food & beverage: $3,233Education: $23
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $232 |
| Merck Sharp & Dohme LLC | 9 | $220 |
| Janssen Biotech, Inc. | 8 | $183 |
| PFIZER INC. | 10 | $183 |
| BeOne Medicines USA, Inc. | 10 | $166 |
| E.R. Squibb & Sons, L.L.C. | 9 | $151 |
| Genentech USA, Inc. | 6 | $137 |
| Novartis Pharmaceuticals Corporation | 7 | $134 |
| Celgene Corporation | 5 | $122 |
| Gilead Sciences, Inc. | 5 | $109 |
Products named: KEYTRUDA, OPDIVO, BRUKINSA, IMFINZI, Trodelvy, Orserdu, REBLOZYL, EPKINLY.
Industry payments across AL — which companies pay providers there.
